| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.42 | 0.1 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.043 | 0.1 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |